Posted Feb. 14, 2013 at 8:33 a.m.

Premium Lock OxyBio strikes supply, manufacturing deal for skin product

Published: 2013-02-14 08:33:00
Updated: 2013-02-14 08:33:00

Print this blog post
Oxygen Biotherapeutics

Oxygen Biotherapeutics (Nasdaq: OXBT) has struck a new supply agreement and distribution agreement with a Swiss firm that will make the company’s cosmetic skin product Dermacyte....



Read More
Read More

WRAL Tech Wire any time: Twitter, Facebook

Copyright 2014 WRAL Tech Wire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Scroll